Prot# NU 05C3: A Phase II Safety Study of Bevacizumab in Patients with Multiple Recurrent or Progressive Malignant Gliomas

Project: Research project

Project Details

StatusFinished
Effective start/end date3/15/063/15/07

Funding

  • Genentech, Inc. (PRESPEND)